Patient information for LANSOPRAZOLE 30MG ORODISPERSIBLE TABLETS Including dosage instructions and possible side effects. orodispersible tablets lansoprazole. Read all of this leaflet carefully before you start taking this medicine because it contains important. To view details for LANSOPRAZOLE 30MG ORODISPERSIBLE TABLETS, please read and accept the disclaimer or go back to product listing for.
|Published (Last):||17 August 2013|
|PDF File Size:||10.12 Mb|
|ePub File Size:||13.84 Mb|
|Price:||Free* [*Free Regsitration Required]|
We comply with the HONcode standard for trustworthy health information – verify here. Stevens-Johnson syndrome, toxic epidermal necrolysis.
Lansoprazole is not significantly eliminated by haemodialysis. Co-administration of lansoprazole and digoxin may lead to increased digoxin plasma levels.
tablete In patients not fully healed the treatment may be continued for another four weeks. The unwanted effects often improve as your body adjusts to the new medicine, but speak with your doctor or pharmacist if any of the following continue or become troublesome.
Very rarely cases of colitis have been reported in patients taking lansoprazoe. Pregnancy There is limited amount of data from the use of lansoprazol in pregnant women. Acid is produced naturally in your stomach to help you digest food and to kill bacteria.
Lansoprazole is a specific inhibitor of the parietal cell proton pumps. What Lansoprazole 30 mg Orodispersible Tablets look like and contents of the pack Lansoprazole 30 mg orodispersible tablets are white to yellowish white uncoated tablets, speckled with orange to dark brown pellets.
Due to reduced clearance of lansoprazole in the elderly an adjustment of dose may be necessary based on individual requirements. Reproductive system and breast disorders.
Lansoprazole 30mg Orodispersible Tablets
Hypomagnesaemia see section 4. For instructions on administration see section 6.
Glossitis, candidiasis of the oesophagus, pancreatitis, taste disturbances. I understand that this information is a copy of the Summary of Product Characteristics and patient information leaflet for a medicine, which outline the conditions under which the medicine should be used and information on its known safety.
LANSOPRAZOLE 30MG ORODISPERSIBLE TABLETS |
The expiry date refers to the last day of that month. Medicinal products transported by P-glycoprotein Lansoprazole has been observed to inhibit the transport protein, P-glycoprotein P-gp in vitro.
Treatment of gastric ulcer: Monitoring of tacrolimus plasma concentrations is advised when concomitant treatment with lanzoprazole is initiated or ended. The effects of overdose on lansoprazole in humans are not known although the acute toxicity is likely to be low and consequently instruction for treatment cannot be given.
Thank you, lansoprazple just sent a survey email to confirm your preferences. During treatment with antisecretory medicinal products, serum gastrin increases in response to the decreased acid secretion. Take them to your local pharmacy which will dispose of them for you. This medicine is for you.
These effects are generally mild and do not last long.
LANSOPRAZOLE 30MG ORODISPERSIBLE TABLETS
Enter medicine name or company Start typing to retrieve search suggestions. The dose may be increased up to 30 mg once daily as necessary. Some of this increase may be due to other risk factors. The most common side-effects are stomach upset and headache. In most affected patients, hypomagnesaemia improved after magnesium replacement and discontinuation of the PPI.
Medicinal products carried by P-glycoprotein Lansoprazole has been observed to inhibit the transport protein, P-glycoprotein P-gp in vitro. Not all pack sizes may be marketed.
Discuss with your doctor, nurse or pharmacist if you are unsure about anything. This is often referred to as ‘ acid reflux ‘.